https://biotechmorning.com/news/lilly-ghosted-rigel-ripk1-deal Biotech Morning en 2026-04-23T14:13:18.405Z Lilly Just Ghosted a $960 Million Drug Deal https://biotechmorning.com/news/merck-billion-dollar-google-cloud-ai-deal Biotech Morning en 2026-04-23T14:12:32.008Z Merck Just Bet $1 Billion That Google Can Fix Drug Development https://biotechmorning.com/news/daraxonrasib-pancreatic-cancer-first-line-results Biotech Morning en 2026-04-23T14:11:49.120Z The Drug That Might Rewrite Pancreatic Cancer's Brutal Math https://biotechmorning.com/news/137m-bet-cancer-smart-bombs-sidewinder Biotech Morning en 2026-04-23T14:11:08.868Z The $137M Bet on Cancer's Smart Bombs https://biotechmorning.com/news/gene-therapy-deaf-hear-whispers Biotech Morning en 2026-04-23T14:10:26.881Z The Gene Therapy That's Making Deaf People Hear Whispers https://biotechmorning.com/news/novartis-abelacimab-anticoagulant-retreat Biotech Morning en 2026-04-23T14:09:48.037Z Novartis Just Spent $925M on a Drug That Can't Beat the Reigning Champ https://biotechmorning.com/news/lilly-300m-crossbridge-bio-dual-payload-adc Biotech Morning en 2026-04-23T14:09:04.056Z Lilly's $300M Bet on a Biotech That Doesn't Even Have a Drug in Humans Yet https://biotechmorning.com/news/ray-therapeutics-125m-series-b-vision-restoration Biotech Morning en 2026-04-22T14:10:48.773Z The $125M Bet on Making Blind Eyes See Again https://biotechmorning.com/news/undruggable-kras-g12d-zoldonrasib-lung-cancer Biotech Morning en 2026-04-22T14:10:07.920Z The "Undruggable" Cancer Target That Just Got Drugged https://biotechmorning.com/news/pbm-drug-price-transparency-fight Biotech Morning en 2026-04-22T14:09:25.208Z The $10,000-a-Day Fine That Has PBMs Sweating https://biotechmorning.com/news/flagship-serif-biomedicines-modified-dna-launch-2 Biotech Morning en 2026-04-22T14:08:43.760Z Flagship's New Bet: A DNA That Acts Like mRNA's Cooler, Longer-Lasting Cousin https://biotechmorning.com/news/tortugas-neuroscience-106m-cns-launch Biotech Morning en 2026-04-22T14:07:52.441Z The Sage Vets Who Raised $106M to Take Another Swing at the Brain https://biotechmorning.com/news/idvynso-two-drug-hiv-pill-fda-approval Biotech Morning en 2026-04-22T14:07:09.080Z The Two-Drug HIV Pill That Wasn't Supposed to Make It